Gilead CFO & Communications Officer Buy Shares, Signaling Confidence in Biotech Growth
Gilead’s recent insider buying shows leadership confidence amid patent cliffs, market access pressures and M&A opportunities in antiviral therapeutics.
4 minutes to read
